Lactulose treatment for hepatic encephalopathy, gastrointestinal symptoms, and health-related quality of life

乳果糖 肝性脑病 肝硬化 医学 内科学 胃肠病学 生活质量(医疗保健) 脑病 护理部
作者
Evangelos Kalaitzakis,Einar Stefan Bjornsson
出处
期刊:Hepatology [Lippincott Williams & Wilkins]
卷期号:46 (3): 949-950 被引量:19
标识
DOI:10.1002/hep.21760
摘要

We read with great interest the article by Prasad et al.1 regarding the effect of lactulose therapy on cognitive function and health-related quality of life (HRQOL) in patients with cirrhosis and minimal hepatic encephalopathy. The authors randomly assigned 61 patients with minimal hepatic encephalopathy to receive lactulose treatment or no treatment in a nonblinded fashion. After 3 months of therapy, the lactulose-treated group exhibited significant improvement in cognitive function (measured by means of 6 neuropsychiatric tests) and HRQOL (measured by means of the Sickness Impact profile) compared with the untreated group of patients with minimal hepatic encephalopathy. Thus, this study provides important data supporting the concept that hepatic encephalopathy per se is linked to HRQOL impairment in cirrhosis and that lactulose treatment may help improve both cognition and HRQOL in this group of patients. Several factors have been reported to influence HRQOL in patients with cirrhosis, including cirrhosis severity,2 cirrhosis-specific symptoms such as muscle cramps and pruritus,2 hepatic encephalopathy (overt or minimal),2, 3 and psychological factors.4 Recently, we performed a prospective study evaluating gastrointestinal symptom severity and HRQOL in 128 consecutive patients with liver cirrhosis using validated questionnaires.5 We found that patients with liver cirrhosis showed increased severity of gastrointestinal symptoms compared with a control population, which was associated with impaired HRQOL. Twenty-nine percent of patients with cirrhosis included in our study were taking lactulose as a treatment for hepatic encephalopathy, and, interestingly, lactulose treatment was found to be independently related to gastrointestinal symptom severity. Daily lactulose use was also negatively related to HRQOL expressed as the physical SF-36 component summary score (biseral correlation coefficient r = −0.27; P < 0.005).5 Lactulose is known to accelerate colonic transit,6 and, due to a narrow therapeutic window, it can lead to diarrhea. Colonic lactulose fermentation can also induce bloating and abdominal distension.7 Although lactulose is known to induce gastrointestinal symptoms,8 this has only rarely resulted in withdrawal of therapy.9 However, gastrointestinal side effects have only vaguely been reported in clinical trials evaluating the effect of lactulose on hepatic encephalopathy.10 In the article by Prasad et al., it is mentioned that none of the patients reported side effects related to lactulose therapy1 but it is unclear whether patients included were actively evaluated for the occurrence and severity of gastrointestinal symptoms. Although it is unlikely that gastrointestinal symptoms due to lactulose had any significant effect on HRQOL in the patients included in this study,1 it should be noted that lactulose use as a treatment of hepatic encephalopathy in everyday clinical practice (that is, outside the controlled conditions of a clinical trial) may be implicated in increased gastrointestinal symptom severity and, consequently, reduced HRQOL. Improved physician and patient awareness about the actions of lactulose could potentially help decrease its side effects. Evangelos Kalaitzakis M.D., Ph.D.*, Einar Björnsson M.D., Ph.D.*, * Section of Gastroenterology and Hepatology, Department of Internal Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
bien完成签到,获得积分10
1秒前
2秒前
传奇3的应助被伶俐的雁梅采纳,获得10
2秒前
2秒前
3秒前
4秒前
lyz完成签到,获得积分10
4秒前
5秒前
6秒前
在水一方的应助被桃子汽水采纳,获得10
6秒前
6秒前
6秒前
7秒前
7秒前
7秒前
7秒前
9秒前
韵掀发布了新的文献求助10
9秒前
十一完成签到,获得积分20
9秒前
10秒前
风吹麦浪发布了新的文献求助30
10秒前
10秒前
丁真人发布了新的文献求助10
10秒前
10秒前
10秒前
ggk发布了新的文献求助10
11秒前
mia发布了新的文献求助10
11秒前
清脆小土豆完成签到 ,获得积分10
12秒前
无极微光的应助被abcd采纳,获得20
12秒前
11完成签到,获得积分10
12秒前
13秒前
13秒前
六道发布了新的文献求助10
14秒前
风吹麦浪发布了新的文献求助10
14秒前
风吹麦浪发布了新的文献求助10
14秒前
bibi11发布了新的文献求助10
14秒前
14秒前
十一发布了新的文献求助10
14秒前
15秒前
lyt发布了新的文献求助10
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183792
求助须知:如何正确求助?哪些是违规求助? 9573020
关于积分的说明 21828776
捐赠科研通 7780959
什么是DOI,文献DOI怎么找? 3434116
关于科研通互助平台的介绍 2558301
邀请新用户注册赠送积分活动 2480611